September/October 2012

Impact of L-Methylfolate Combination Therapy Among Diabetic Peripheral Neuropathy Patients

October 17, 2012

The American Journal of Pharmacy Benefits

Patients with diabetic peripheral neuropathy taking L-methylfolate, pyridoxal-5'-phosphate, and methylcobalamin (MPM) had lower all-cause hospitalization risk and healthcare costs than patients not taking MPM.

Importance of Pattern Management for Glycemic Control: The OneTouch VerioIQ Meter

October 17, 2012

The American Journal of Pharmacy Benefits

The OneTouch VerioIQ Meter uses pattern recognition technology for self-monitoring of blood glucose, a key part of treatment management in patients with type 1 and type 2 diabetes.

Statin-Fenofibrate Combination Therapy in an ACCORD Population: A Retrospective Analysis

October 17, 2012

The American Journal of Pharmacy Benefits

Retrospective analysis of a population meeting criteria for the ACCORD lipid trial supported adjunct fenofibrate in patients with reduced low-density lipoprotein cholesterol and elevated triglycerides.

Trends in the 2012 Eisai Oncology Digest: Insurance and Cost Obstacles in Cancer Treatment

October 17, 2012

The American Journal of Pharmacy Benefits

Results from Eisai Inc's online national survey of cancer patients, published in the 2012 Eisai Oncology Digest, highlight financial concerns of cancer treatment and their impact on treatment adherence.